Imperial College London

Professor Sarah Fidler BSc. MBBS. FRCP. PhD

Faculty of MedicineDepartment of Infectious Disease

Professor of HIV and Communicable Diseases



+44 (0)20 7594 6230s.fidler




clinical trial centre Winston Churchill wingMedical SchoolSt Mary's Campus





Professor Sarah Fidler is a clinical academic who provides care for people living with HIV. Her main research interest is in the diagnosis, treatment and cure of HIV infection. 



Fogel JM, Wilson EA, Piwowar-Manning E, et al., 2022, HIV drug resistance in a community-randomized trial of universal testing and treatment: HPTN 071 (PopART), Journal of the International Aids Society, Vol:25

Hargreaves JR, Pliakas T, Hoddinott G, et al., 2022, The association between HIV stigma and HIV incidence in the context of universal testing and treatment: analysis of data from the HPTN 071 (PopART) trial in Zambia and South Africa, Journal of the International Aids Society, Vol:25

Ogbe A, Pace M, Bittaye M, et al., 2022, Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV, Jci Insight, Vol:7

Lee MJ, Collins S, Babalis D, et al., 2022, The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with recent HIV infection-study protocol for a two-stage randomised phase II trial, Trials, Vol:23, ISSN:1745-6215

Bareng OT, Moyo S, Zahralban-Steele M, et al., 2022, HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana, Journal of Antimicrobial Chemotherapy, Vol:77, ISSN:0305-7453, Pages:1385-1395

More Publications